首页> 外文期刊>The Neurohospitalist >Acute Ischemic Stroke and Transient Ischemic Attack: An Update on Recent Practically Relevant Clinical Trials
【24h】

Acute Ischemic Stroke and Transient Ischemic Attack: An Update on Recent Practically Relevant Clinical Trials

机译:急性缺血性中风和短暂性脑缺血发作:最近实际相关临床试验的更新。

获取原文
获取原文并翻译 | 示例
           

摘要

This short review focuses on recent practically relevant studies in stroke treatment and prevention and discusses their implications on clinical practice and future research, including 3 shortly published randomized controlled trials investigating interventional treatment in acute ischemic stroke (The Inter-ventional Management of Stroke phase III trial [IMS III], Synthesis Expansion: A Randomized Controlled Trial on Intra-Arterial Versus Intravenous Thrombolysis in Acute Ischemic Stroke, and the Mechanical Retrieval and Recanali-zation of Stroke Clots Using Embolectomy [MR RESCUE]) and 1 large trial on secondary prevention in high-risk patients with transient ischemic attack (TIA) or minor stroke (Randomized, Double-blind Trial Comparing the Effects of a 3-month Clopidogrel Regimen, Combined With ASA During the First 21 days, Versus ASA Alone for the Acute Treatment of TIA or Minor Stroke [CHANCE trial]).
机译:这篇简短的综述着重于卒中治疗和预防方面的近期实用研究,并讨论了它们对临床实践和未来研究的影响,包括3篇近期发表的随机对照试验,研究了急性缺血性卒中的介入治疗(卒中介入治疗III期试验) [IMS III],合成扩展:急性缺血性卒中中动脉内溶栓与静脉溶栓的随机对照试验,以及使用栓子切除术对中风凝块进行机械取回和再血管化[MR RESCUE])和一项关于在第二级预防中进行二级预防的大型试验短暂性脑缺血发作(TIA)或轻度卒中的高危患者(随机,双盲试验比较了头21天为期3个月的氯吡格雷方案与ASA联合使用的效果,相对于ASA单独用于TIA的急性治疗或中风[机会尝试]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号